Search Results - "Korovkin, A S"

Adverse Events Following Vaccination: A Review of Russian and International Terminology by Korovkin, A. S., Gorenkov, D. V.

“…SCIENTIFIC RELEVANCE. Inconsistent terminology for vaccine safety may create challenges for healthcare professionals in identifying, interpreting, and…”
Get full text

Approaches to vaccination of adults against pneumococcal disease in different countries of the world by Korovkin, A. S., Obukhov, Yu. I., Syatchikhina, E. N.

“…Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms…”
Get full text

Prospectives of developing therapeutic HPV vaccines by Raevskaya, Natalja M., Nikitina, T. N., Simbirtsev, A. S., Solovyeva, I. L., Volgin, A. R., Korovkin, A. S.

“…Human papillomavirus (HPV) represents one of the most serious global public health problems. Malignant female and male diseases mainly result from persistent…”
Get full text

Development of Technology for the Preparation of Pegylated Filgrastim and Studies of its Physicochemical and Biological Properties by Lonshakov, D. V., Sheremet’ev, S. V., Bobrysheva, I. V., Grebennikova, O. A., Khursevich, E. M., Korovkin, S. A.

Get full text

Study of reactogenicity, safety and immunogenicity of inactivated virosomal split influenza vaccine "Grifor" during phase I clinical trial by Zverev, V V, Korovkin, S A, Mironov, A N, Mel'nikov, S Ia, Mikhaĭlova, N A, Kostinov, M P, Dyldina, N V, Zhirova, S N

“…Phase I clinical trial of inactivated virosomal split influenza vaccine "Grifor" was conducted in the Mechnikov Research Institute of Vaccines and Sera as…”
Get more information

Assessment of “Specific Safety” Index of the Live Tularemia Vaccine by Barulina, I. S., Sayapina, L. V., Baidalova, N. P., Khoreva, I. I., Mescheryakova, I. S., Kormilitsyna, M. I., Korovkin, S. A.

“…Analyzed were the results of specific safety control of the live tularemia dry vaccine used for tularemia prophylaxis. During the period of 1997-2006 this…”
Get full text

Study of pH-Dependent Kinetics of Filgrastim Pegylation with Succinimide Derivatives of Poly(Ethylene Glycol) and Comparison of the Properties of Pegylated Forms Obtained Under Various Conditions by Lonshakov, D. V., Sheremet’ev, S. V., Khursevich, E. M., Bobrysheva, I. V., Grebennikova, O. A., Korovkin, S. A.

“…Filgrastim was pegylated by acylation with a linear 20-kDa pegylating agent (PEG agent) to search for conjugates characterized by biological activity…”
Get full text

Synthesis and Pharmacological Properties of Linear Poly(Ethylene Glycol)s Conjugated to Interferon α-2b by Azo Coupling by Sheremet’ev, S. V., Lonshakov, D. V., Korovkin, S. A., Belosludtseva, E. M., Katlinskii, A. V., Semchenko, A. V., Borisova, O. V.

“…A method for the preparation of pharmacologically active conjugates of interferon α-2b with poly(ethylene glycol)s that absorbed in the visible spectral range…”
Get full text

Synthesis and Pharmacological Properties of Linear Polys Conjugated to Interferon [alpha]-2b by Azo Coupling by Sheremet'ev, S. V, Lonshakov, D. V, Korovkin, S. A, Belosludtseva, E. M, Katlinskii, A. V, Semchenko, A. V, Borisova, O. V

“…A method for the preparation of pharmacologically active conjugates of interferon [alpha]-2b with poly(ethylene glycol)s that absorbed in the visible spectral…”
Get full text

Results and prospects of rotavirus immunisation in the Russian Federation by Korovkin, A. S., Ignatyev, G. M.

“…Scientific relevance . Rotavirus disease and its consequences remain a leading vaccine-preventable cause of mortality in young children. Russia has not yet…”
Get full text

Prophylaxis of respiratory syncytial virus infection: current status and prospects for vaccine development by Korovkin, A. S., Gorenkov, D. V., Volgin, A. R.

“…INTRODUCTION . Respiratory syncytial virus (RSV) is one of the most widespread pathogens that typically cause acute upper and lower respiratory tract…”
Get full text

Current regulatory requirements for stability studies of biological medicinal products: a review by Soldatov, A. A., Yakovlev, A. K., Avdeeva, Zh. I., Gorenkov, D. V., Korovkin, A. S., Kosenko, V. V.

“…INTRODUCTION. The stability assessment of biological medicinal products (BMPs) requires special approaches and regulatory requirements. Therefore, BMPs require…”
Get full text

Human papillomavirus vaccines: organisation and experience of preclinical studies by Korovkin, A. S., Nikitina, T. N., Kozlova, T. Yu, Gorenkov, D. V., Volgin, A. R.

“…INTRODUCTION . Vaccination is the main measure for the primary prevention of human papillomavirus (HPV)-related diseases. The development of novel vaccine…”
Get full text

C235-V3 cyclotron for a proton therapy center to be installed in the hospital complex of radiation medicine (Dimitrovgrad) by Galkin, R. V., Gurskii, S. V., Jongen, Y., Karamysheva, G. A., Kazarinov, M. Yu, Korovkin, S. A., Kostromin, S. A., Calderan, J. -M., Cahay, P., Mokrenko, S. P., Morozov, N. A., Nkongolo, H., Ol’shevskii, A. G., Paradis, Y., Petrov, D. S., Romanov, V. M., Samsonov, E. V., Syresin, E. M., Shakun, A. N., Shakun, N. G., Shirkov, G. D., Shirkov, S. G.

“…Proton therapy is an effective method of treating oncologic diseases. In Russia, construction of several centers for proton and ion therapy is slated for the…”
Get full text

Protective Properties of Inactivated Virosomal Influenza Vaccine by Erofeeva, М.К., Nickonorov, I.J., Maksakova, V.L., Stukova, M.A., Konshina, O.S., Okhapkina, E.A., Voicehovskaya, E.M., Korovkin, S.A., Melnikhov, S.J., Kiselev, O.I.

“…Currently, application of new technological solutions for the implementation of strategies for improving influenza vaccines are up to date and modern. In this…”
Get full text

Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines by Merkulov, V A, Lebedev, V N, Plekhanova, T M, Maksimov, V A, Korovkin, S A, Mironov, A N

“…Perspectives of using reverse genetics methods for constructing of recombinant influenza virus strains acceptable for use as live attenuated vaccines are…”
Get more information

Clinical trial of safety and immunogenicity of new influenza vaccine Grifor in children by Erofeeva, M K, Mel'nikov, S Ia, Semchenko, A V, Korovkin, S A, Nikonorov, I Iu, Maksakova, V L, Voĭtsekhovskaia, E M, Erman, E S, Gonchar, V V, Pozdeev, V K, Drinevskiĭ, V P

“…Assessment of reactogenicity, safety and immunogenicity after single intramuscular immunization of children with Grifor vaccine. Reactogenicity, safety, and…”
Get more information

Development and preclinical study of new generation virosomal split influenza vaccine "Grifor" by Mel'nikov, S Ia, Zverev, V V, Korovkin, S A, Mironov, A N, Dyldina, N V, Mikhaĭlova, N A, Faĭzuloev, E B, Lotte, V D

“…New Russian virosomal split vaccine against influenza "Grifor" was developed. The vaccine is represented by mix of highly purified protective external and…”
Get more information

Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2) by Mazurkova, N A, Ryndiuk, N N, Shishkina, L N, Ternovoĭ, V A, Tumanov, Iu V, Bulychev, L E, Skarnovich, M O, Kabanov, A S, Panchenko, S G, Aleĭnikov, R P, Il'ina, T N, Kuzubov, V I, Mel'nikov, S Ia, Mironov, A N, Korovkin, S A, Sergeev, A N, Drozdov, I G

“…Results of phase II of a clinical trial of the influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2) are presented. The vaccine was developed…”
Get more information

Clinical trial of new inactivated influenza vaccine "Grifor" by Zverev, V V, Kiselev, O I, Korovkin, S A, Mironov, A N, Mel'nikov, S Ia, Mikhaĭlova, N A, Kostinov, M P, Erofeeva, M K, Solomina, A A, Dyldina, N V, Zhirova, S N, Stukova, M A

“…To confirm and prove on the extended contingent of volunteers the non-reactogenicity, safety and immunogenicity of "Grifor" vaccine in comparative trial with…”
Get more information